Search

Search Results

• HIV-ASSOCIATED VENOUS THROMBOEMBOLISM

  Michele Bibas, Gianluigi Biava, Andrea Antinori

  e2011030

  2011-07-08

  https://doi.org/10.4084/mjhid.2011.030

  4257

  PDF: 1504

  HTML: 8524

• IMPACT OF QUALITATIVE AND QUANTITATIVE IMMUNOPARESIS ON EARLY INFECTION RISK IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA Immunoparesis and early infection risk in myeloma

  Hongfeng Wang, Jianbin Chen

  e2026062

  2026-06-30

  https://doi.org/10.4084/MJHID.2026.062

  125

  PDF: 313

  HTML: 43

• Guest Editor: Pellegrino Musto HOW FIRST-LINE THERAPY IS CHANGING IN NON-TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS.

  Daniele Derudas

  e2025025

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.025

  1591

  PDF: 1404

  HTML: 139

• ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OF THE ELDERLY: REVIEW OF THE LITERATURE AND PERSPECTIVES. Hematopoietic stem cell transplatation in the elderly fo Acute Myeloid Leukemia

  Gabriele Magliano, Andrea Bacigalupo

  e2020081

  2020-10-27

  https://doi.org/10.4084/mjhid.2020.081

  1680

  PDF: 527

  HTML: 170

• FEASIBILITY AND OUTCOME OF FIRST-LINE AUTOTRANSPLANT-BASED TREATMENT IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS AGED > 65 YEARS: MONOCENTRIC RETROSPECTIVE REAL-WORLD ANALYSIS Outcomes of ASCT in NDMM elderly fit patients

  Paola Stefanoni, Monica Galli, Laura Paris, Alessandro Rambaldi, Nicola Pittalis, Gianluca Cavallaro, Chiara Pavoni

  e2024066

  2024-08-31

  https://doi.org/10.4084/MJHID.2024.066

  1069

  PDF: 638

  Html: 165

• REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy

  Ulrike Bacher, Simon Brechbühl, Barbara Jeker, Thomas Pabst

  e2021012

  2021-01-01

  https://doi.org/10.4084/mjhid.2021.012

  1624

  PDF: 644

  HTML: 632

• AGE-STANDARDIZED INCIDENCE RATES FOR LEUKEMIA ASSOCIATED WITH CONSANGUINEOUS MARRIAGES IN 68 COUNTRIES, AN ECOLOGICAL STUDY

  Mostafa Saadat

  e2015027

  2015-04-21

  https://doi.org/10.4084/mjhid.2015.027

  1607

  PDF: 921

  HTML: 1823

• PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD

  Beatrice Autino, Yolanda Corbett, Francesco Castelli, Donatella Taramelli

  e2012061

  2012-10-04

  https://doi.org/10.4084/mjhid.2012.061

  4600

  PDF: 1956

  HTML: 17861

• INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH CHRONIC LYMPHOPROLIFERATIVE DISORDERS IN THE ERA OF TARGET DRUGS

  Livio Pagano, Davide Facchinelli, Dr.

  e2018063

  2018-10-27

  https://doi.org/10.4084/mjhid.2018.063

  2088

  PDF: 1132

  HTML: 231

• Sickle Cell Disease: Management options and challenges in developing countries

  Daniel Ansong, Alex Osei-Akoto, Delaena Ocloo, Kwaku Ohene-Frempong Ohene-Frempong

  e2013062

  2013-11-04

  https://doi.org/10.4084/mjhid.2013.062

  2585

  PDF: 1311

  HTML: 1041

• DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.

  Maria Concetta Postorino, Filippo Luciani, Carmelo Mangano, Maria Stella Carpentieri, Paolo Scerbo, Armando Priamo, Giuseppina Berardelli, Roberto Marino, Alfredo Vallone, Nicola Serrao, Vincenzo Pisani, Chiara Costa, Albano Terremoto, Giuseppe Foti, Lucio Cosco, Massimo Calderazzo, Domenico Corigliano, Preziosa Scordo, Carlo Torti, Alessio Strazzulla

  e2015054

  2015-10-08

  https://doi.org/10.4084/mjhid.2015.054

  1635

  PDF: 818

  HTML: 1242

  Figure 1: 183

  Figure 2: 196

  Figure 3: 194

• BEHÇET’S SYNDROME AND THROMBOSIS

  Emire Seyahi, Sebahattin Yurdakul

  e2011026

  2011-07-08

  https://doi.org/10.4084/mjhid.2011.026

  2958

  PDF: 1694

  HTML: 17010

• Morphologic leukemia-free state after venetoclax-based therapy in acute myeloid leukemia is associated with high relapse despite preserved short-term survival

  Kenta Motegi

  e2026048

  2026-04-30

  https://doi.org/10.4084/MJHID.2026.048

  314

  PDF: 321

  HTML: 77

• Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All Trans Retinoic Acid: A Monocentric Experience. Coagulopathy in APL treated with ATRA and Arsenic Trioxide.

  Francesco Autore, Patrizia Chiusolo, Federica Sora', Luca Laurenti, Livio Pagano, Andrea Bacigalupo, Valerio De Stefano, Simona Sica

  e2023009

  2023-01-01

  https://doi.org/10.4084/MJHID.2023.009

  1134

  PDF: 1092

  HTML: 459

• CIRCRNA CIRCEHBP1 REGULATES THE MATURATION OF MIR-129 TO INCREASE THE CHEMORESISTANCE OF CANCER CELLS TO ADRIAMYCIN IN ACUTE MYELOID LEUKAEMIA

  Hong Li, Kehong Bi, Saran Feng, Yan Wang, Chuansheng Zhu

  e2022062

  2022-08-27

  https://doi.org/10.4084/MJHID.2022.062

  649

  PDF: 519

  HTML: 201

• CHARACTERIZATION AND ANTIMICROBIAL SUSCEPTIBILITY PROFILE OF SEPTICAEMIA-CAUSING PATHOGENS ISOLATED FROM FEBRILE CHILDREN WITH SICKLE CELL DISEASE IN KANO, NIGERIA.

  Ibrahim Yusuf

  e2018016

  2018-02-15

  https://doi.org/10.4084/mjhid.2018.016

  2920

  PDF: 1000

  HTML: 527

• SHORT HISTORY OF MALARIA AND ITS ERADICATION IN ITALY

  Giancarlo Majori

  e2012016

  2012-03-10

  https://doi.org/10.4084/mjhid.2012.016

  4987

  PDF: 1943

  HTML: 11196

  Fig 1: 240

  Fig 2: 198

  Fig 3: 320

  Fig 4: 202

  Fig 5: 203

  Fig 6: 194

  Fig 7: 217

  Fig 8: 197

• IMPORTANCE OF HYPERBILURUBINEMIA IN DIFFERENTIATION OF PRIMARY AND SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN PEDIATRIC CASES

  seval ozen, alper Dai, enes coskun, serdar oztuzcu, sercan ergun, elif aktekin, sibel yavuz, Ali Bay

  e2014067

  2014-10-28

  https://doi.org/10.4084/mjhid.2014.067

  1812

  PDF: 952

  HTML: 1117

  Untitled: 172

  Untitled: 191

  Untitled: 172

  Untitled: 173

• Is there a better therapeutic time window from diagnosis to treatment elderly acute myeloid leukemia patients receiving hypomethylating agents?

  Salvatore Perrone

  e2024055

  2024-06-29

  https://doi.org/10.4084/MJHID.2024.055

  596

  PDF: 817

  HTML: 106

• FLUDARABINE-MELPHALAN-CAMPATH FOLLOWED BY UNMANIPULATED PERIPHERAL-BLOOD HAEMATOPOIETIC STEM CELLS CAN STILL CURE LYMPHOMA.

  Daniele Avenoso, Amal Alabdulwahab, Michelle Kenyon, Varun Mehra, Pramila Krishnamurthy, Francesco Dazzi, Ye Ting Leung, Sandra Anteh, Mili Naresh Shah, Andrea Kuhnl, Robin Sanderson, Piers Patten, Deborah Yallop, Antonio Pagliuca, Victoria Potter

  e2023041

  2023-06-29

  https://doi.org/10.4084/MJHID.2023.041

  1644

  PDF: 735

  HTML: 227

• TREATMENT OF ADOLESCENT AND YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

  Josep-Maria Ribera, Jordi Ribera, Eulàlia Genescà

  e2014052

  2014-07-02

  https://doi.org/10.4084/mjhid.2014.052

  2736

  PDF: 1372

  HTML: 5915

• THALASSEMIA AND VENOUS THROMBOEMBOLISM

  Julien Succar, Khaled M. Musallam, Ali T Taher

  e2011025

  2011-05-25

  https://doi.org/10.4084/mjhid.2011.025

  2990

  PDF: 1047

  HTML: 4608

• AGING WITH THALASSEMIA AND SICKLE CELL DISEASE: A GERONTOLOGICAL MODEL OF ACCELERATED MULTIMORBIDITY AND FUNCTION-CENTERED CARE BEYOND MIDLIFE Thalassemia and Sickle Cell Diseases: Effect of Aging

  Dr.Sophia Delicou, Dr.Ioannis Ilias, Dr.Athanasia Kapota, Dr.Elena Papatheodorou, Dr.Maria Moraki, Dr.Aikaterini Xydaki, Dr.Alexandra Mika, Dr.Panagiota Giannou, Dr.Irene Kouroukli, Dr.Theodoros Aforozis, Dr.Myrto Palkopoulou, Dr.Christos Savvidis, Dr.Iliana Mani, Prof.Constantina Aggeli, Prof. John Koskinas

  e2026039

  2026-04-30

  https://doi.org/10.4084/MJHID.2026.039

  439

  PDF: 430

  Suppl. Files: 60

  HTML: 32

• Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.

  Dina Khalaf, Bassem Toema, Nidal Dabbour, Fathi Jehani

  e2011004

  2011-01-04

  https://doi.org/10.4084/mjhid.2011.004

  1819

  PDF: 556

  HTML: 16986

  Figure 4: 178

  Figure 3: 151

  Figure 2: 157

  Figure 1: 193

• Acute Hemolytic Anemia Following Rasburicase in a Very Late Post-Transplant Relapse of Acute Myeloid Leukemia

  Gianluca Cavallaro, Federico Lussana, Marco Frigeni, Maria Caterina Micò, Alessandra Algarotti, Anna Grassi, Orietta Spinelli, Chiara Pavoni, Elena Oldani, Alessandro Rambaldi

  e2026003

  2026-01-01

  https://doi.org/10.4084/MJHID.2026.003

  625

  PDF: 533

  Html: 112

• DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES

  Prof. Giuseppe Leone, Emiliano Fabiani, Maria Teresa Voso

  e2022030

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.030

  1427

  HTML: 486

  PDF: 846

• CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.

  Vincenzo De Sanctis

  e2020006

  2020-01-01

  https://doi.org/10.4084/mjhid.2020.006

  4323

  PDF: 1542

  HTML: 462

• ZIKA VIRUS: A REVIEW FROM THE VIRUS BASICS TO PROPOSED MANAGEMENT STRATEGIES

  Lorenzo Zammarchi, Michele Spinicci, Alessandro Bartoloni

  e2016056

  2016-11-01

  https://doi.org/10.4084/mjhid.2016.056

  5174

  PDF: 1257

  HTML: 2065

• ENDOTHELIAL NITRIC OXIDE SYNTHASE (ENOS) GENE POLYMORPHISM IS ASSOCIATED WITH AGE ONSET OF MENARCHE IN SICKLE CELL DISEASE FEMALES OF INDIA

  Sudhansu Sekhar Nishank

  e2013036

  2013-06-04

  https://doi.org/10.4084/mjhid.2013.036

  1571

  PDF: 942

  HTML: 2377

  Table: 198

• Monoclonal Gammopathy of Undetermined Significance Disguised as Chronic Neutrophilic Leukemia

  Monique A Hartley-Brown, Lubomir Sokol, Gisela L Caceres, Mohammed A Hussein, Alan List, Javier Pinilla-Ibarz

  e2010002

  2010-02-23

  https://doi.org/10.4084/mjhid.2010.002

  1069

  PDF: 560

  HTML: 407

• How I treat acute and persistent sickle cell pain

  Samir Ballas

  e2020064

  2020-09-08

  https://doi.org/10.4084/mjhid.2020.064

  2012

  PDF: 1132

  HTML: 495

• ECONOMIC EVALUATION OF CHELATION REGIMENS FOR ?--THALASSEMIA MAJOR: A SYSTEMATIC REVIEW

  Jialian Li

  e2019036

  2019-06-24

  https://doi.org/10.4084/mjhid.2019.036

  2039

  PDF: 1473

  HTML: 235

• OUTCOME OF FRONTLINE TREATMENT WITH “GENERIC” IMATINIB IN ADULT PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN ALGERIAN POPULATION: A MULTICENTER STUDY

  Mohamed Amine BEKADJA

  e2017062

  2017-10-25

  https://doi.org/10.4084/mjhid.2017.062

  2909

  PDF: 747

  HTML: 915

• PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION

  Isidro Jarque, Miguel Salavert, Javier Pemán

  e2016035

  2016-07-01

  https://doi.org/10.4084/mjhid.2016.035

  3748

  PDF: 1257

  HTML: 3911

  Untitled: 239

  Untitled: 275

• MIGRATION AND MALARIA IN EUROPE

  Begoña Monge-Maillo, Rogelio López-Vélez

  e2012014

  2012-03-10

  https://doi.org/10.4084/mjhid.2012.014

  3434

  PDF: 1146

  HTML: 4669

• Covid-19; Cholera and Crimean-Congo hemorrhagic fever in Iraq: A country with three outbreaks

  Nawfal R Hussein

  e2022077

  2022-10-29

  https://doi.org/10.4084/MJHID.2022.077

  643

  PDF: 418

  HTML: 248

• HYDROXYCARBAMINE: FROM AN OLD DRUG USED IN MALIGNANT HEMOPATHIES TO A CURRENT STANDARD IN SICKLE CELL DISEASE

  Giovanna Cannas, Solene Poutrel, Xavier Thomas

  e2017015

  2017-02-15

  https://doi.org/10.4084/mjhid.2017.015

  3996

  PDF: 1194

  HTML: 1661

• Third party cord blood transplant boosts autologous hematopoiesis in a case of persistent bone marrow aplasia after double transplant failure for ?-thalassemia major

  Giuseppe Visani, Paola Picardi, Barbara Guiduccu, Claudio Giardini, Moira Lucesole, Sara Barulli, Teresa Ricciardi, Federica Loscocco, Alessandro Isidori

  e2013029

  2013-04-15

  https://doi.org/10.4084/mjhid.2013.029

  1508

  PDF: 860

  HTML: 1238

• CIRCCTNNA1 IS UPREGULATED IN MANTLE CELL LYMPHOMA AND PREDICTS POOR SURVIVAL BY SPONGING MIR-34A TO INCREASE CELL PROLIFERATION.

  Xuebing Jing, Cong Lu, Chao Song, Qingkun Han

  e2022047

  2022-06-29

  https://doi.org/10.4084/MJHID.2022.047

  689

  PDF: 533

  HTML: 227

• PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN HBV,HCV and HIV and Sickle Cell Disease.

  Anil Pathare, Salam Alkindi, prof.

  e2019058

  2019-10-30

  https://doi.org/10.4084/mjhid.2019.058

  1680

  PDF: 1023

  HTML: 375

• ROLE OF CYTOKINES AS MOLECULAR MARKER OF DENGUE SEVERITY

  Priyanka Sehrawat, Ashutosh Biswas, Prabhat Kumar, Paras Singla, Naveet Wig, Lalit Dar, Rita Sood

  e2018023

  2018-04-20

  https://doi.org/10.4084/mjhid.2018.023

  3231

  PDF: 1190

  HTML: 465

• AGE AT DIAGNOSIS OF SICKLE CELL ANAEMIA IN LAGOS, NIGERIA

  Femi Akodu, I N Diaku-Akinwumi, O F Njokanma

  e2013001

  2013-01-02

  https://doi.org/10.4084/mjhid.2013.001

  2046

  PDF: 923

  HTML: 1875

• APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE

  Alberto L. García-Basteiro, Quique Bassat, Pedro L. Alonso

  e2012015

  2012-03-10

  https://doi.org/10.4084/mjhid.2012.015

  2617

  PDF: 993

  HTML: 15126

• Hemophagocytic lymphohistiocytosis secondary to refractory acute myeloid leukemia resolved after second line treatment with azacitidine plus venetoclax

  Claudio Fozza

  e2024011

  2024-01-01

  https://doi.org/10.4084/MJHID.2024.011

  1708

  PDF: 1389

  HTML: 188

• PROGNOSTIC IMPACT OF IMMUNOHISTOCHEMICAL P53 EXPRESSION IN BONE MARROW BIOPSY IN HIGHER RISK MDS: A PILOT STUDY

  Alfredo Molteni, Emanuele Ravano, Marta Riva, Michele Nichelatti, Laura Bandiera, Lara Crucitti, Mauro Truini, Roberto Cairoli

  e2019015

  2019-02-26

  https://doi.org/10.4084/mjhid.2019.015

  1897

  PDF: 1003

  HTML: 337

• TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL

  Giorgia Sulis, Alberto Roggi, Alberto Matteelli, Mario C. Raviglione

  e2014070

  2014-10-27

  https://doi.org/10.4084/mjhid.2014.070

  7157

  PDF: 4028

  HTML: 24901

• CLINICAL ANALYSIS AND OPTIMIZATION OF POST-REMISSION THERAPY FOR ACUTE MYELOID LEUKEMIA PATIENTS WITH MINIMAL RESIDUAL DISEASE AS DETERMINED BY FLOW CYTOMETRY

  Daichi Inoue, Hayato Maruoka, Takayuki Takahashi

  e2010020

  2010-08-05

  https://doi.org/10.4084/mjhid.2010.020

  1318

  PDF: 757

  HTML: 1182

• CHARACTERISTICS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA IN MULTI-TRANSFUSED PATIENTS WITH THALASSEMIA MAJOR. EXPERIENCE OF A SINGLE TERTIARY CENTER.

  Nikolaos Papadopoulos, Dimitrios Kountouras, Katerina Malagari, Maria Tampaki, Maria Theochari, John Koskinas

  e2020013

  2020-02-26

  https://doi.org/10.4084/mjhid.2020.013

  1780

  PDF: 972

  HTML: 227

• NOVEL DRUGS IN FOLLICULAR LYMPHOMA

  Giuseppe Rossi, Antonella Anastasia

  e2016061

  2016-11-01

  https://doi.org/10.4084/mjhid.2016.061

  4573

  PDF: 1539

  HTML: 1565

  Untitled: 243

• LONGITUDINAL STUDY ON LIVER FUNCTIONS IN PATIENTS WITH THALASSEMIA MAJOR BEFORE AND AFTER DEFERASIROX (DFX) THERAPY

  Ashraf Tawfik Soliman, Mohamed Yassin, Fawzia AlYafei, Lolwa Al-Naimi, Noora Almarri, Aml Sabt, Vincenzo De Sanctis

  e2014025

  2014-04-06

  https://doi.org/10.4084/mjhid.2014.025

  2303

  PDF: 2180

  HTML: 2444